BEADLE, Christopher David,COATES, David Andrew,HAO, Junliang,KRUSHINSKI JR., Joseph Herman,REINHARD, Matthew Robert,SCHAUS, John Mehnert,WOLFANGEL, Craig Daniel
申请号：
AU2016238934
公开号：
AU2016238934B2
申请日:
2016.10.07
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016238934B220170803.pdf#####3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract HO )n OH NR OR R3 The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
